Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
CAS Number: 130-86-9
fluorocyclopentenylcytosine
Retinoid differentiation therapy for common types of acute myeloid leukemia
914471-09-3
Solubility: DMSO: 9 mg/mL(34
CAL-101 - CAS# 870281-82-6 richlormethiazide CAS Number: 130-86-9Idelalisib, also known as CAL 101, is a PI3K delta inhibitor with potential immunomodulating and antineoplastic activities. CAL 101 inhibits the production of the second messenger phosphatidylinositol 3,4,5 trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and thus inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K delta is expressed primarily in hematopoietic lineages. The
US$ 109.17
US$ 427.50
US$ 2149.00
US$ 388.50
US$ 691.00
US$ 646.50
US$ 395.00
US$ 817.50
US$ 523.50
US$ 427.50
US$ 427.50
US$ 802.50
US$ 427.50
US$ 817.50